125 related articles for article (PubMed ID: 30221734)
1. Dicer affects cisplatin‑mediated apoptosis in epithelial ovarian cancer cells.
Wang X; Chen H; Wen Y; Yang X; Han Q; Jiang P; Huang Z; Cai J; Wang Z
Mol Med Rep; 2018 Nov; 18(5):4381-4387. PubMed ID: 30221734
[TBL] [Abstract][Full Text] [Related]
2. Interference with endogenous EZH2 reverses the chemotherapy drug resistance in cervical cancer cells partly by up-regulating Dicer expression.
Cai L; Wang Z; Liu D
Tumour Biol; 2016 May; 37(5):6359-69. PubMed ID: 26631032
[TBL] [Abstract][Full Text] [Related]
3. Silencing Dicer expression enhances cellular proliferative and invasive capacities in human tongue squamous cell carcinoma.
Zeng S; Yang J; Zhao J; Liu Q; Rong M; Guo Z; Gao W
Oncol Rep; 2014 Feb; 31(2):867-73. PubMed ID: 24317682
[TBL] [Abstract][Full Text] [Related]
4. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
[TBL] [Abstract][Full Text] [Related]
5. Role of Dicer in regulating oxaliplatin resistance of colon cancer cells.
Lai HH; Lin LJ; Hung LY; Chen PS
Biochem Biophys Res Commun; 2018 Nov; 506(1):87-93. PubMed ID: 30336979
[TBL] [Abstract][Full Text] [Related]
6. Galectin-3 regulates chemotherapy sensitivity in epithelial ovarian carcinoma via regulating mitochondrial function.
Wang D; You D; Li L
J Toxicol Sci; 2019; 44(1):47-56. PubMed ID: 30626779
[TBL] [Abstract][Full Text] [Related]
7. Adipose‑derived mesenchymal stem cells attenuate cisplatin‑induced apoptosis in epithelial ovarian cancer cells.
Wen Y; Guo Y; Huang Z; Cai J; Wang Z
Mol Med Rep; 2017 Dec; 16(6):9587-9592. PubMed ID: 29039536
[TBL] [Abstract][Full Text] [Related]
8. Depletion of Dicer promotes epithelial ovarian cancer progression by elevating PDIA3 expression.
Zhu Y; Cai L; Guo J; Chen N; Yi X; Zhao Y; Cai J; Wang Z
Tumour Biol; 2016 Oct; 37(10):14009-14023. PubMed ID: 27492604
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of dicer as a result of reduced let-7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells.
Jakymiw A; Patel RS; Deming N; Bhattacharyya I; Shah P; Lamont RJ; Stewart CM; Cohen DM; Chan EK
Genes Chromosomes Cancer; 2010 Jun; 49(6):549-59. PubMed ID: 20232482
[TBL] [Abstract][Full Text] [Related]
10. Dicer ablation promotes a mesenchymal and invasive phenotype in bladder cancer cells.
Lombard AP; Lim RM; Nakagawa RM; Vidallo KD; Libertini SJ; Platero AJ; Mudryj M
Oncol Rep; 2015 Sep; 34(3):1526-32. PubMed ID: 26166215
[TBL] [Abstract][Full Text] [Related]
11. p53 Promotes chemoresponsiveness by regulating hexokinase II gene transcription and metabolic reprogramming in epithelial ovarian cancer.
Han CY; Patten DA; Lee SG; Parks RJ; Chan DW; Harper ME; Tsang BK
Mol Carcinog; 2019 Nov; 58(11):2161-2174. PubMed ID: 31486135
[TBL] [Abstract][Full Text] [Related]
12. siRNA targeting of PRDX3 enhances cisplatin‑induced apoptosis in ovarian cancer cells through the suppression of the NF‑κB signaling pathway.
Duan J; Lang Y; Song C; Xiong J; Wang Y; Yan Y
Mol Med Rep; 2013 May; 7(5):1688-94. PubMed ID: 23503975
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of Dicer in MCF-7 human breast carcinoma cells results in G1 arrest and increased sensitivity to cisplatin.
Bu Y; Lu C; Bian C; Wang J; Li J; Zhang B; Li Z; Brewer G; Zhao RC
Oncol Rep; 2009 Jan; 21(1):13-7. PubMed ID: 19082437
[TBL] [Abstract][Full Text] [Related]
14. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G
Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression.
Rupaimoole R; Ivan C; Yang D; Gharpure KM; Wu SY; Pecot CV; Previs RA; Nagaraja AS; Armaiz-Pena GN; McGuire M; Pradeep S; Mangala LS; Rodriguez-Aguayo C; Huang L; Bar-Eli M; Zhang W; Lopez-Berestein G; Calin GA; Sood AK
Oncogene; 2016 Aug; 35(33):4312-20. PubMed ID: 26725326
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.
Zhang X; Huang L; Zhao Y; Tan W
Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606
[TBL] [Abstract][Full Text] [Related]
17. Concordant and discordant regulation of target genes by miR-31 and its isoforms.
Chan YT; Lin YC; Lin RJ; Kuo HH; Thang WC; Chiu KP; Yu AL
PLoS One; 2013; 8(3):e58169. PubMed ID: 23472152
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of dicer expression in ovarian cancer tissues.
Pampalakis G; Diamandis EP; Katsaros D; Sotiropoulou G
Clin Biochem; 2010 Feb; 43(3):324-7. PubMed ID: 19782670
[TBL] [Abstract][Full Text] [Related]
19. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
Ma JJ; Chen BL; Xin XY
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744
[TBL] [Abstract][Full Text] [Related]
20. AC1MMYR2, an inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression.
Shi Z; Zhang J; Qian X; Han L; Zhang K; Chen L; Liu J; Ren Y; Yang M; Zhang A; Pu P; Kang C
Cancer Res; 2013 Sep; 73(17):5519-31. PubMed ID: 23811941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
